NCT05887492
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05887492
Title Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Tango Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology/Oncology Santa Monica California 90404 United States Details
SCRI at HealthOne Denver Colorado 80218 United States Details
Florida Cancer Specialists Sarasota Florida 34232 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Health System Detroit Michigan 48202 United States Details
START MidWest Grand Rapids Michigan 49546 United States Details
NYU Langone Hematology Oncology Associates-Mineola Mineola New York 11501 United States Details
New York University Langone Health New York New York 10016 United States Details
Sarah Cannon Tennessee Oncology Nashville Tennessee 37203 United States Details
US Oncology Investigational Products Center Dallas Texas 75246 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology Virginia Fairfax Virginia 22031 United States Details
US Oncology Investigational Products Center Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field